https://www.selleckchem.com/pr....oducts/simnotrelvir.
vidence for pediatric patients constituting a low-risk group for COVID-19. Retrospective analysis of data from PneuNET registry to evaluate clinical follow up of patients with typical and atypical bronchopulmonary carcinoid (bpNET). Three lung cancer centres in Berlin included patients in the registry between 2007 and 2016. Inclusion criteria were diagnosis of typical or atypical carcinoid, age 18 years, follow-up for not less than 2 years. Frequency, gender, functional status, smoking status, localisation of the tumour, bio
Like
Comment
Share
